期刊文献+

0.1%普拉洛芬滴眼液在白内障手术前后应用对术后炎症的控制作用 被引量:9

暂未订购
导出
摘要 目的:通过评价白内障手术前后应用普拉洛芬滴眼液对术后炎症的治疗效果,寻求一种白内障术后炎症药物控制的较佳方案。方法:行白内障超声乳化联合人工晶体植入术的老年性白内障非住院病例104例(104眼),将病例随机分入四组:术后单独滴用氟米龙滴眼液组(甲组)、术后联合用药组(乙组)、术前1d始滴普拉洛芬滴眼液术后联合用药组(丙组)、术前3d始滴普拉洛芬滴眼液术后联合用药组(丁组)。手术方法采用标准超声乳化白内障吸除联合人工晶体植入术。术后第1、3、7、15、30天观察症状和体征并进行评分。应用SPSS10.0统计软件进行数据处理,以P<0.05判定差异有统计学意义。结果:101例(101眼)完成研究。术后第1、3天时丁组综合评分明显低于其他组(P<0.05),术后3、7天时甲组综合评分比其他组统计学意义高(P<0.05);术后15天和30天时四组间综合评分差异无统计学意义(P>0.05)。结论:术前应用非甾体抗炎药物做预处理,术后联合应用非甾体抗炎药物与糖皮质激素是白内障超声乳化吸除联合人工晶体植入术后炎症控制的较佳治疗方案。
出处 《吉林医学》 CAS 2008年第19期1638-1639,共2页 Jilin Medical Journal
  • 相关文献

参考文献5

  • 1赵家良,黎晓新,董冬生,陈有信,邹燕红,张移,普拉洛芬临床试验组.普拉洛芬滴眼液治疗白内障术后炎症和非感染性眼前段炎症的临床评价[J].眼科研究,2000,18(6):560-564. 被引量:170
  • 2Kensaku Miyake, Kanjiro Masuda, Shiroaki Shirato, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: A multicentered prospective trial[ J ]. Jpn J Ophthalrno, 2000, 44 : 58.
  • 3Anna Zaczek, Carl, Gustaf Laurell, Charlotta Zetterstr,et al. Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment [ J ]. J Cataract Refract Surg, 2004, 30 : 316.
  • 4Holzer MP, Solomon KD, Sandoval HP, et al. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: Prospective. randomized double -masked study[ J ]. Cataract Refract Surg, 2002, 28: 93.
  • 5Hayasaka Y, Hayasaka S, Zhang XY, et al. Effects of topical anti - inflammatory, and antiallergic eyedrops on prostaglandin E2 induced aquleous flare elevation in pigmented rabbits [ J ]. Arch Ophthalmol, 2092, 120(7) : 950.

二级参考文献8

  • 1[1]Ogawa T, Ogasawara A. Effects of Proanoprofen on rabbit uveitis. Journal of the Eye,1988,5: 1335
  • 2[2]Ogawa T, Ogasawara A, Yamamoto Y. Anti-inflammatory activity of Pranoprofen ophthalmic solution on rat experimental conjunctivitis. Folia Ophthalmol Jpn, 1982,33: 1244
  • 3[3]Kitano S,Ochi T,Uchida Y,et al. Study on the effect of Pranoprofen (Y8004) ophthalmic solution on postoperative inflammation and its optimal concentration. Japanese Review of Clinical Ophthalmology, 1985,79: 425
  • 4[4]Kitano S,Uchida Y,Shimizu H,et al. Clinical study of 0.1% Pranoprofen (Y-8004) ophthalmic solution for the treatment of subacute and chronic conjunctivitis. A double-blind controlled trial with 0.05% dexamethasone ophthalmic solution. Japanese Review of Clinical Ophthalmology, 1985,79:432
  • 5[5]Kodama Y, Itoi M. Clinical experience with Pronoprofen (Y-8004) ophthalmic solution, a nonsteroidal anti-inflammatory preparation, in the treatment of postoperative inflammation. Japanese Review of Clinical Ophthalmology, 1985,79: 263
  • 6[6]Fukushi S, Suzuki T. Clinical application of Y-8004 (Pranoprofen).Japanes of Clinical Ophthalmology, 1984,78: 734
  • 7[7]Yamamura T, Yokoyama S, Sasaki K. Clinical Study on the effect of Pranoprofen ophthalmic solution in anterior uveitis. Folia Ophthalmol Jpn,1983,34: 1872
  • 8[8]Nituvol R, Martinez M, Bergamini VW, et al. Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Am J Ophthalmol, 1994,117:651

共引文献169

同被引文献47

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部